degenerative), and dialysis (0% postdissection, 3% degenerative). Mean follow-up was 14 6 11 months. At 2 years, there was no difference (P > .05) in patient survival (81% 6 8% vs 73% 6 0.5%), freedom from aortic death (98% 6 2% vs 97% 6 1%), primary (95% 6 2% vs 97% 6 1%) and secondary target artery patency (99% 6 1% vs 99% 6 0.6%), target artery instability (89% 6 3% vs 93% 6 1%), and freedom from secondary interventions (68% 6 8% vs 78% 6 4% at 1 year) for postdissection and degenerative TAAAs, respectively (Table) .
Objective: Adding ipsilateral, retrograde endovascular intervention (IPE) to carotid endarterectomy (CEA) for treatment of tandem bifurcation and supra-aortic trunk disease is controversial. Some suggest this combined strategy (CEA + IPE) confers no risk over isolated CEA. Others disagree, reserving CEA + IPE for symptomatic patients. Using the Vascular Quality Initiative (VQI), this study assessed the effect of adding IPE to CEA on stroke and death risk. We further weighed CEA + IPE outcomes in the context of symptomatic status and Society for Vascular Surgery guidelines.
Methods: All CEAs in the VQI database from March 2003 to March 2017 were reviewed. Urgent and redo CEAs were excluded. CEA + IPE procedures were identified. To isolate effect of IPE, patients undergoing other concurrent procedures were removed, providing an isolated CEA cohort. Primary end points were perioperative (30-day) stroke and death. Univariate and logistic regression analyses were performed.
Results: After exclusion and identification of CEA + IPE, 66,519 procedures were available for analysis. Of these, 66,115 represented isolated CEA and 404 CEA + IPE. Most patients (60%) were male, 93% were white, and 41% were symptomatic. Average age was 70 6 9 years. Those undergoing CEA + IPE were more likely to be female (50% vs 40%; P < .0005), to be smokers (87% vs 76%; P < .0005), and to have coronary artery disease (32% vs 27%; P ¼ .04), congestive heart failure (14% vs 10%; P ¼ .01), and chronic obstructive pulmonary disease (30% vs 22%; P < .0005). Isolated CEA patients were more likely to have severe ipsilateral stenosis (86% vs 80%; P ¼ .002) and to undergo intraoperative shunting (53% vs 49%; P ¼ .05). There was no difference in 30-day mortality between cohorts (1% vs 1%; p ¼ .23). However, CEA + IPE had higher rates of perioperative stroke (3.0% vs 1.4%; p ¼ .01) and combined 30-day stroke and death (3.5% vs 1.8%; P ¼ .02). When stratified by symptomatic status, there were no differences in primary end points between cohorts in asymptomatic patients. In symptomatic patients, CEA + IPE carried significantly higher stroke (5% vs 2%; P ¼ .002) and stroke and death risk (6% vs 2%; P ¼ .001). After adjusting for age and comorbidities, independent predictors of stroke and death were diabetes (odds ratio [OR], 1.2; P ¼ .001), symptomatic status (OR, 1.7; P < .0005), and CEA + IPE (OR, 1.9; P ¼ .02).
Conclusions: Addition of IPE to CEA confers increased stroke and death risk over isolated CEA. Risk is largely in symptomatic patients. Although CEA + IPE increases risk compared with isolated CEA, overall risk remains low. Based on this VQI analysis, CEA + IPE outcomes for asymptomatic patients fall within Society for Vascular Surgery guidelines for isolated CEA. Those for symptomatic patients do not, and consideration should be given to other surgical bypass, cerebral protection, and staged strategies.
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Response Objective: Exertional muscular compression of the popliteal artery (PA) in the proximal calf can be associated with lower extremity (LE) pain and neurologic symptoms. Exertional ankle-brachial index (EABI) and dynamic PA imaging are routinely used to identify this syndrome of functional popliteal entrapment, but neither has been rigorously studied. Our objective was to characterize the response of the PA to LE exertion and extrinsic compression in symptomatic and asymptomatic limbs.
Methods: Limbs characterized as symptomatic (n ¼ 29) or asymptomatic (n ¼ 61) had duplex ultrasound PA diameter and peak systolic velocity (PSV) measurements in neutral and maximal ankle plantar flexion positions. EABIs were obtained at rest and 1 minute and 5 minutes after walking (5 minutes, 3 mph,10-degree incline) and running (5 minutes, 6 mph, 0 degrees). Significance was set at P ¼ .05. Data are expressed as mean 6 standard error of the mean.
Results: Plantar flexion resulted in PA occlusion and changes in diameter and PSV in symptomatic (three occluded, À2.4 6 0.34 mm, +49 cm/ s) and asymptomatic (six occluded, À1.6 6 0.21 mm, +65 cm/s) limbs. Difference in percentage change was significant between groups only for diameter (Fig 1) . EABIs were similar at rest, decreased with running and walking at 1 minute, and were not fully recovered by 5 minutes. EABI decrease was greater after running and significantly more pronounced in symptomatic (16% at 1 minute) than in asymptomatic (1.2%) limbs (Fig 2) . Conclusions: EABI decrease with running and PA diameter decrease with ankle plantar flexion are greater in limbs with than without exertional LE. These measurements may be valuable as noninvasive tests in the workup for functional popliteal entrapment syndrome.
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Contemporary Outcomes and Management of Complex Vascular Surgical Groin Wound Infections
Salim Lala, Salvatore T. Scali, Sarah E. Gray, Kristina A. Giles, Martin R. Back, Javairiah Fatima, Dean Arnaoutakis, Thomas S. Huber. University of Florida, Gainesville, Fla
Objective: Isolated vascular surgical groin wound infections (VS-GWIs) have multiple causes and frequently present as limb-or life-threatening problems, resulting in significant morbidity and mortality. For patients undergoing femoral reconstruction, interposition iliofemoral replacement or extra-anatomic bypass can be used; however, limited data exist comparing different reconstruction strategies or conduit subtypes. Therefore, we sought to describe our experience with management of VS-GWIs and to compare different conduit choices.
Methods: All patients at a single university hospital (2002) (2003) (2004) (2005) (2006) (2007) (2008) (2009) (2010) (2011) (2012) (2013) (2014) (2015) (2016) undergoing treatment of VS-GWI due to primary mycotic or infected pseudoaneurysm secondary to percutaneous intervention or previous prosthetic graft placement were identified. The primary end point was the major adverse limb event (MALE; major amputation, graft occlusion, and open or endovascular reintervention on index limb) rate. Secondary end points included complications and wound healing. Intergroup comparison of outcomes was made between different reconstruction (interposition replacement, extra-anatomic) and conduit choices (autogenous femoral or saphenous vein; antibiotic-impregnated prosthetic graft; cadaveric femoral artery or vein).
Results: There were 158 patients identified (mean age, 65.6 6 12 years; 70% male, 81% hypertension, 52% coronary disease, 37% chronic pulmonary, 16% congestive heart failure), of whom 128 (81%) had unilateral and 30 (19%) had bilateral VS-GWIs. Indications included infected prosthetic bypass/pseudoaneurysm (89%, n ¼ 140; infrainguinal, 116; suprainguinal, 24) and primary mycotic femoral artery complications from percutaneous intervention (11%, n ¼ 18). A majority underwent interposition reconstruction (92%; n ¼ 145); the remaining patients received femoral ligation with or without staged repair (n ¼ 8; 5 with staged reconstruction and 5 without in patients with prior limb amputation) or extra-anatomic bypass (axillofemoral + superficial femoral artery reimplantation, n ¼ 3; transobturator, n ¼ 2). Autogenous conduit was used most commonly (66%; n ¼ 99 of 153), of which 80 (81%) were femoral vein. The remaining patients received cadaveric (19%; n ¼ 28) or prosthetic (14%; n ¼ 21; 13, rifampin-soaked Dacron; 8, polytetrafluoroethylene) grafts. Adjunctive myocutaneous muscle flap was used in 34% (n ¼ 53; sartorius, n ¼ 48; rectus femoris, n ¼ 3; gracilis, n ¼ 2). Overall mean length of stay was 19.3 6 16 days, and 30-day mortality was 6% (n ¼ 9). At time of last follow-up, all living patients had healed femoral wounds; however, 48% (n ¼ 76) experienced reoperation (graft-related endovascular or open 
